Your browser doesn't support javascript.
loading
Genomic ALK alterations in primary and relapsed neuroblastoma.
Rosswog, Carolina; Fassunke, Jana; Ernst, Angela; Schömig-Markiefka, Birgid; Merkelbach-Bruse, Sabine; Bartenhagen, Christoph; Cartolano, Maria; Ackermann, Sandra; Theissen, Jessica; Blattner-Johnson, Mirjam; Jones, Barbara; Schramm, Kathrin; Altmüller, Janine; Nürnberg, Peter; Ortmann, Monika; Berthold, Frank; Peifer, Martin; Büttner, Reinhard; Westermann, Frank; Schulte, Johannes H; Simon, Thorsten; Hero, Barbara; Fischer, Matthias.
Afiliação
  • Rosswog C; Department of Experimental Pediatric Oncology, University Children's Hospital of Cologne, Medical Faculty, University of Cologne, Cologne, Germany.
  • Fassunke J; Center for Molecular Medicine Cologne (CMMC), Medical Faculty, University of Cologne, Cologne, Germany.
  • Ernst A; Else Kröner Forschungskolleg Clonal Evolution in Cancer, University Hospital of Cologne, Cologne, Germany.
  • Schömig-Markiefka B; Department of Pediatric Oncology and Hematology, University Children's Hospital of Cologne, Medical Faculty, University of Cologne, Cologne, Germany.
  • Merkelbach-Bruse S; Institute of Pathology, University Hospital of Cologne, Cologne, Germany.
  • Bartenhagen C; Department of Pediatric Oncology and Hematology, University Children's Hospital of Cologne, Medical Faculty, University of Cologne, Cologne, Germany.
  • Cartolano M; Institute of Pathology, University Hospital of Cologne, Cologne, Germany.
  • Ackermann S; Institute of Pathology, University Hospital of Cologne, Cologne, Germany.
  • Theissen J; Department of Experimental Pediatric Oncology, University Children's Hospital of Cologne, Medical Faculty, University of Cologne, Cologne, Germany.
  • Blattner-Johnson M; Center for Molecular Medicine Cologne (CMMC), Medical Faculty, University of Cologne, Cologne, Germany.
  • Jones B; Center for Molecular Medicine Cologne (CMMC), Medical Faculty, University of Cologne, Cologne, Germany.
  • Schramm K; Department of Experimental Pediatric Oncology, University Children's Hospital of Cologne, Medical Faculty, University of Cologne, Cologne, Germany.
  • Altmüller J; Center for Molecular Medicine Cologne (CMMC), Medical Faculty, University of Cologne, Cologne, Germany.
  • Nürnberg P; Department of Experimental Pediatric Oncology, University Children's Hospital of Cologne, Medical Faculty, University of Cologne, Cologne, Germany.
  • Ortmann M; Department of Pediatric Oncology and Hematology, University Children's Hospital of Cologne, Medical Faculty, University of Cologne, Cologne, Germany.
  • Berthold F; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.
  • Peifer M; Division of Pediatric Glioma Research, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany.
  • Büttner R; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.
  • Westermann F; Division of Pediatric Glioma Research, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany.
  • Schulte JH; Department of Pediatric Oncology, Hematology, Immunology and Pulmonology, Heidelberg University Hospital, Heidelberg, Germany.
  • Simon T; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.
  • Hero B; Division of Pediatric Glioma Research, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany.
  • Fischer M; Cologne Center for Genomics (CCG), University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany.
Br J Cancer ; 128(8): 1559-1571, 2023 04.
Article em En | MEDLINE | ID: mdl-36807339

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Receptores Proteína Tirosina Quinases / Neuroblastoma Tipo de estudo: Risk_factors_studies Limite: Child / Humans Idioma: En Revista: Br J Cancer Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Alemanha

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Receptores Proteína Tirosina Quinases / Neuroblastoma Tipo de estudo: Risk_factors_studies Limite: Child / Humans Idioma: En Revista: Br J Cancer Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Alemanha